Atopic dermatitis and fungi

被引:128
作者
Faergemann, J [1 ]
机构
[1] Sahlgrens Univ Hosp, Dept Dermatol, S-41345 Gothenburg, Sweden
关键词
D O I
10.1128/CMR.15.4.545-563.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Atopic dermatitis (AD) is a chronic, itching, inflammatory skin disease which is associated with asthma and/or hay fever and a familial occurrence of these conditions. Genetic factors are important in the development of AD, but the exact hereditary pathway is still unknown. Dry skin and the weakened barrier function in patients with AD is very important for the patient's reactions to irritants and other external trigger factors including microorganisms. The standard treatments are topical corticosteroids, topical immunomodulating agents, and emollients. If AD cannot be controlled by this type of treatment, systemic immunomodulating agents may be used. UVB, UVA, or psoralen-UVA may also be used for widespread severe lesions. However, some patients do not respond to these standard treatment, and then it is important to consider the role of microorganisms, house dust mites or food. The role of the Malassezia yeasts in AD, especially AD located to the head and neck region, is now documented in several papers. There are also several papers indicating the role of Candida as an aggravating factor in AD. Patients with AD also develop chronic dermatophyte infections more easily, and patients with AD and chronic dermatophyte infections may show improvement in their AD when treated with antifungal drugs.
引用
收藏
页码:545 / +
页数:20
相关论文
共 169 条
  • [1] Abeck D, 1998, BRIT J DERMATOL, V139, P13
  • [2] Adachi A, 1999, Arerugi, V48, P719
  • [3] Changes in Staphylococcus aureus density and lesion severity after topical application of povidone-iodine in cases of atopic dermatitis
    Akiyama, H
    Tada, J
    Toi, Y
    Kanzaki, H
    Arata, J
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 1997, 16 (01) : 23 - 30
  • [4] [Anonymous], ACTA DERM VENERE S92, DOI [10.2340/00015555924447, DOI 10.2340/00015555924447]
  • [5] [Anonymous], N NOTIZ GEB NAT HEIK
  • [6] Arzumanyan V. G., 2001, Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, P29
  • [7] Yeast fungi in patients with allergic diseases: Species variety and sensitivity to antifungal drugs
    Arzumanyan, VG
    Magarshak, OO
    Semenov, BF
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2000, 129 (06) : 601 - 604
  • [8] Ashbee H R, 1994, Exp Dermatol, V3, P106, DOI 10.1111/j.1600-0625.1994.tb00267.x
  • [9] KETOCONAZOLE IN ATOPIC-DERMATITIS - THERAPEUTIC RESPONSE IS CORRELATED WITH DECREASE IN SERUM IGE
    BACK, O
    SCHEYNIUS, A
    JOHANSSON, SGO
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 1995, 287 (05) : 448 - 451
  • [10] Systemic ketoconazole for yeast allergic patients with atopic dermatitis
    Bäck, O
    Bartosik, J
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2001, 15 (01) : 34 - 38